G-CSF therapy of healthy stem cell donors decreases neutrophil chemotaxis and this effect may also contribute to the reduced chemotaxis in sepsis patients even though the G-CSF responsiveness of neutrophils seems to be decreased in sepsis patients compared with healthy individuals [405,436]. This evidence concerns the gene CSF3 and Sepsis.